Skip to main content
Top
Published in: AIDS Research and Therapy 1/2022

Open Access 01-12-2022 | Human Immunodeficiency Virus | Research

Effects of psychosocial factors on nonadherence to ART in Ganta, Nimba county, Liberia

Authors: Philomena J. Strother, Mathuros Tipayamongkholgul, Varakorn Kosaisevee, Nawarat Suwannapong

Published in: AIDS Research and Therapy | Issue 1/2022

Login to get access

Abstract

Background

It has been widely noted that lifetime adherence to antiretroviral therapy (ART) is necessary for HIV treatment outcome; however, retention on ART among people living with HIV (PLWH) remains a great challenge to achieve the Global AIDS Strategy: End inequalities, End AIDS. Nonadherence to ART is one of the HIV care problem in Liberia despite the availability of free ART. Psychosocial factors, i.e., perceived stigma and social support likely contributed to nonadherence to ART. We investigated associations among clinical factors, psychosocial factors, and nonadherence to ART.

Methods

A community-based cross-sectional study was conducted among 185 PLWH, age ≥ 18 years receiving ART in Ganta, Nimba county, Liberia at least 3 months. The structured questionnaire was used to collect data from April to May 2020. Associated factors of nonadherence to ART were identified using multivariable binary logistic regression, and the p-value < 0.05 was considered statistically significant.

Results

Of 185 respondents, 62.2% showed nonadherence to ART. Females reported higher nonadherence compared with males (64.4% vs. 56.6%). Multivariable binary logistic regression revealed strong experiences of stigma (PORadj = 2.392, p-value = 0.018), poor information support (PORadj = 2.102, p-value = 0.026) increased prevalence of ART nonadherence among Liberian PLWH.

Conclusions

The healthcare providers may apply interventions to reduce perceived stigma and to enhance continuous information provision in addition to support from health care providers and family members. An intensive monitoring of ART side effects is needed to be strengthened in particular among newly started ART patients.
Literature
22.
go back to reference Friedland BA, Gottert A, Hows J, et al. The People Living with HIV Stigma Index 2.0: generating critical evidence for change worldwide. AIDS. 2020;34 (Suppl 1):S5–18.CrossRef Friedland BA, Gottert A, Hows J, et al. The People Living with HIV Stigma Index 2.0: generating critical evidence for change worldwide. AIDS. 2020;34 (Suppl 1):S5–18.CrossRef
27.
go back to reference Yam EA, Pulerwitz J, Almonte D, et al. Stigma among key populations living with HIV in the Dominican Republic: experiences of people of haitian descent, MSM, and female sex workers. AIDS. 2020;34 (Suppl 1):S43–51.CrossRef Yam EA, Pulerwitz J, Almonte D, et al. Stigma among key populations living with HIV in the Dominican Republic: experiences of people of haitian descent, MSM, and female sex workers. AIDS. 2020;34 (Suppl 1):S43–51.CrossRef
29.
go back to reference Dudley JR. Confronting stigma within the services system. Soc Work. 2000;45:449–55.CrossRef Dudley JR. Confronting stigma within the services system. Soc Work. 2000;45:449–55.CrossRef
31.
go back to reference House J. Social support and social structure. Sociol Forum. 1987;2 (1):135–46.CrossRef House J. Social support and social structure. Sociol Forum. 1987;2 (1):135–46.CrossRef
Metadata
Title
Effects of psychosocial factors on nonadherence to ART in Ganta, Nimba county, Liberia
Authors
Philomena J. Strother
Mathuros Tipayamongkholgul
Varakorn Kosaisevee
Nawarat Suwannapong
Publication date
01-12-2022
Publisher
BioMed Central
Published in
AIDS Research and Therapy / Issue 1/2022
Electronic ISSN: 1742-6405
DOI
https://doi.org/10.1186/s12981-022-00455-2

Other articles of this Issue 1/2022

AIDS Research and Therapy 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine